-
ICD-10-CM Codes
›
-
A00-B99
›
-
B50-B64
›
-
B55-
›
-
2023 ICD-10-CM Diagnosis Code B55.2
2023 ICD-10-CM Diagnosis Code B55.2
Mucocutaneous leishmaniasis
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
- B55.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2023 edition of ICD-10-CM B55.2 became effective on October 1, 2022.
- This is the American ICD-10-CM version of B55.2 - other international versions of ICD-10 B55.2 may differ.
The following code(s) above
B55.2 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
- Applicable To annotations, or
- Code Also annotations, or
- Code First annotations, or
- Excludes1 annotations, or
- Excludes2 annotations, or
- Includes annotations, or
- Note annotations, or
- Use Additional annotations
that may be applicable to
B55.2:
- Infection by leishmania braziliensis
Clinical Information
- A disease characterized by the chronic, progressive spread of lesions from new world cutaneous leishmaniasis caused by species of the l. Braziliensis complex to the nasal, pharyngeal, and buccal mucosa some time after the appearance of the initial cutaneous lesion. Nasal obstruction and epistaxis are frequent presenting symptoms.
ICD-10-CM B55.2 is grouped within Diagnostic Related Group(s) (MS-DRG v40.0):
- 606 Minor skin disorders with mcc
- 607 Minor skin disorders without mcc
Convert B55.2 to ICD-9-CM
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- American
- Brazilian leishmaniasis B55.2
- Conjunctivitis (staphylococcal) (streptococcal) H10.9
ICD-10-CM Diagnosis Code H10.9
Unspecified conjunctivitis
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
- due to
- mucocutaneous leishmaniasis B55.2
- in (due to)
- mucocutaneous leishmaniasis B55.2
- parasitic
- mucocutaneous leishmaniasis B55.2
- Espundia B55.2
- Infection, infected, infective (opportunistic) B99.9
ICD-10-CM Diagnosis Code B99.9
Unspecified infectious disease
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
- Leishmaniasis B55.9
ICD-10-CM Diagnosis Code B55.9
Leishmaniasis, unspecified
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
- American (mucocutaneous) B55.2
- Brazilian B55.2
- mucocutaneous B55.2 (American) (New World)
- naso-oral B55.2
- nasopharyngeal B55.2
ICD-10-CM Codes Adjacent To B55.2
B52.8 Plasmodium malariae malaria with other complications
B52.9 Plasmodium malariae malaria without complication
B53 Other specified malaria
B53.0 Plasmodium ovale malaria
B53.1 Malaria due to simian plasmodia
B53.8 Other malaria, not elsewhere classified
B55.0 Visceral leishmaniasis
B55.1 Cutaneous leishmaniasis
B55.2
Mucocutaneous leishmaniasis
B55.9 Leishmaniasis, unspecified
B56 African trypanosomiasis
B56.0 Gambiense trypanosomiasis
B56.1 Rhodesiense trypanosomiasis
B56.9 African trypanosomiasis, unspecified
B57.0 Acute Chagas' disease with heart involvement
B57.1 Acute Chagas' disease without heart involvement
B57.2 Chagas' disease (chronic) with heart involvement
B57.3 Chagas' disease (chronic) with digestive system involvement
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
